George B Abercrombie Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

George B Abercrombie is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 36,431 shares of BCRX, which is worth approximately $233,887. The most recent transaction as insider was on Jun 12, 2024, when has been sold 6,820 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.4K

23.03% 3M change

23.03% 12M change

Total Value Held $233,887

GEORGE B ABERCROMBIE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2024	BUY Grant, award, or other acquisition	-	6,820 Added 15.77%	36,431 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	16,745 Added 36.12%	29,611 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	-	12,866 Added 50.0%	12,866 Common Stock
Apr 18 2022	SELL Open market or private sale	$55,200 $11.04 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$16,600 $3.32 p/Share	5,000 Added 50.0%	5,000 Common Stock
Feb 15 2022	SELL Open market or private sale	$92,500 $18.5 p/Share	5,000 Reduced 100.0%	0 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$16,600 $3.32 p/Share	5,000 Added 50.0%	5,000 Common Stock

Nov 15 2021	SELL Open market or private sale	$61,350 $12.27 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$16,600 $3.32 p/Share	5,000 Added 50.0%	5,000 Common Stock
Sep 15 2021	SELL Open market or private sale	$75,300 $15.06 p/Share	5,000 Reduced 100.0%	0 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$13,150 $2.63 p/Share	5,000 Added 50.0%	5,000 Common Stock
Sep 10 2021	SELL Open market or private sale	$1,116,660 $15.09 p/Share	74,000 Reduced 100.0%	0 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$185,310 $2.61 p/Share	71,000 Added 48.97%	74,000 Common Stock
Jul 15 2021	SELL Open market or private sale	$78,450 $15.69 p/Share	5,000 Reduced 62.5%	3,000 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$13,150 $2.63 p/Share	5,000 Added 38.46%	8,000 Common Stock
May 24 2021	SELL Open market or private sale	$92,671 $13.9 p/Share	6,667 Reduced 68.97%	3,000 Common Stock
May 24 2021	BUY Exercise of conversion of derivative security	$17,534 $2.63 p/Share	6,667 Added 40.82%	9,667 Common Stock
May 10 2021	SELL Open market or private sale	$88,900 $12.7 p/Share	7,000 Reduced 70.0%	3,000 Common Stock

GBA

George B Abercrombie

Director

Chapel Hill, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account